We are taught that cheap is value and expensive is growth. Wrong! What if we select stocks based on their actual growth rates, and weight them on the dollar magnitude of that growth? This reimagining of growth investing dominates standard offerings.
Hear from the Author
Interested in having your article published in the Financial Analysts Journal? Find out how.
Abstract
Conventional growth indices suffer from two important shortcomings. First, stocks that are anti-value (very expensive) are not necessarily growth stocks. The decision to include a stock in a growth index should be based on fundamental growth measures, such as growth in sales, profits, or R&D spending, rather than price-based measures. Second, when these indices are weighted by objective measures of growth, rather than by market value, performance markedly improves. Overpaying for growth is unhelpful. We also assert that some stocks with poor growth prospects and unattractive valuations may have no place in either value or growth indices.